Table 2.
NCSs of ulnar and distal sural sensory nerves and the peroneal motor nerve (knee to ankle) unilaterally on the nondominant side in the EURODIAB PCS at follow-up
| Ulnar |
Sural |
Peroneal |
||||
|---|---|---|---|---|---|---|
| Velocity (m/s) | Amplitude (mV) | Velocity (m/s) | Amplitude (mV) | Velocity (m/s) | Amplitude (mV) | |
| CVD | ||||||
| None | 51.2 ± 6.3 | 18.6 ± 12.3 | 45.1 ± 7.0 | 10.3 ± 7.4 | 43.9 ± 4.5 | 5.4 ± 3.2 |
| Present | 48.3 ± 6.7 | 16.8 ± 10.9 | 44.7 ± 6.8 | 8.4 ± 6.7 | 43.0 ± 4.0 | 5.7 ± 4.5 |
| Neuropathy | ||||||
| None | 51.6 ± 5.7 | 19.7 ± 12.5 | 45.4 ± 7.2 | 11.0 ± 7.7 | 44.3 ± 4.5 | 5.7 ± 3.3 |
| Present | 48.7 ± 7.8 | 14.8 ± 10.3 | 44.1 ± 6.3 | 7.4 ± 5.5 | 42.6 ± 4.4 | 4.3 ± 3.1 |
| Albumin excretion | ||||||
| Normal | 51.3 ± 6.1 | 18.9 ± 12.2 | 45.8 ± 7.0 | 10.8 ± 7.8 | 44.3 ± 4.4 | 5.5 ± 3.1 |
| Microalbuminuria | 49.0 ± 7.0 | 15.6 ± 10.7 | 42.1 ± 7.0 | 7.7 ± 5.4 | 41.4 ± 4.6 | 4.1 ± 2.3 |
| Macroalbuminuria | 48.0 ± 8.7 | 11.5 ± 11.1 | 40.3 ± 4.6 | 5.1 ± 4.0 | 41.4 ± 3.6 | 4.0 ± 3.1 |
| Retinopathy | ||||||
| None | 52.1 ± 5.9 | 20.9 ± 13.2 | 47.6 ± 7.7 | 12.4 ± 9.1 | 46.0 ± 3.9 | 5.9 ± 4.0 |
| Nonproliferative | 51.4 ± 6.8 | 18.6 ± 11.8 | 45.0 ± 6.8 | 9.8 ± 6.2 | 43.6 ± 4.6 | 5.1 ± 2.8 |
| Proliferative | 47.5 ± 5.9 | 11.7 ± 8.6 | 41.2 ± 5.3 | 6.5 ± 4.7 | 40.9 ± 4.1 | 3.8 ± 2.7 |
Data are means ± SD and are unadjusted from the complete-case analysis.